FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention related to chemical-pharmaceutical and cosmetic industry, and deals with lamellar form of delivery, dissolving or decomposing in water medium, for release of, at least, one medicinal or cosmetically acting substance into hole or cavity in body, including polymer matrix in form of hardened foam with spaces or cavities, as well as, at least, one medicinal or cosmetic active substance, characterised by the fact, that matrix polymer is represented by grafted copolymer of polyvinyl alcohol and polyethylene glycol, which consists on 75% from polyvinyl alcohol and on 25% from polyethylene glycol. Also described are methods of said medicinal forms manufacturing.
EFFECT: elaboration of lamellar form of medication delivery.
6 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RAPID DEGRADATION DOSAGE FORM RELEASING ACTIVE COMPONENTS INTO ORAL CAVITY OR BODY CAVITIES | 2001 |
|
RU2297213C2 |
| QUICK-BREAKING DOSAGE FORM RELEASING REACTIVE COMPONENTS IN MOUTH OR BODY CAVITIES | 2005 |
|
RU2356533C2 |
| FILMS, DISSOLVING IN MOUTH CAVITY | 2004 |
|
RU2351315C2 |
| FLAT OR LAMELLAR MEDICINAL PREPARATION OF CORRECTED TASTE | 2003 |
|
RU2316316C2 |
| FILM PREPARATIONS RELEASING ACTIVE SUBSTANCE AND METHOD FOR PRODUCING THEREOF | 2003 |
|
RU2316313C2 |
| FILM-TYPE PREPARATIONS OF HIGH CHEMICAL STABILITY, CONTAINING ACTIVE INGREDIENT, AND METHOD FOR PRODUCING THEM | 2003 |
|
RU2311900C2 |
| COMPRESSED PHARMACEUTICAL PRODUCT | 2016 |
|
RU2744270C2 |
| SOLID NICOTINE-CONTAINING DOSAGE FORM WITH REDUCED UNPLEASANT ORGANOLEPTIC IMPACT | 2013 |
|
RU2623018C2 |
| ORAL DOSAGE FORM CONTAINING OUTER COATING FOR FAST RELEASE | 2017 |
|
RU2789054C2 |
| PHARMACEUTICAL DRUG FORM OF TYROSINE KINASE INHIBITOR FOR PERORAL INTRODUCTION | 2007 |
|
RU2468788C2 |
